Discover open access scientific publications

Search, annotate, share and cite publications

Publications by U. Vitolo

Integrating Tumor- And Microenvironment-Reflecting Genes in a Unique and Routine-Applicable Assay for Accurate Risk Prediction in DLBCL

Hematological Oncology

English

Cell of Origin Combined With CNS International Prognostic Index Improves Identification of DLBCL Patients With High CNS Relapse Risk After Initial Immunochemotherapy

Hematological Oncology

English

Pet-Driven Radiotherapy in Patients With Low Risk Diffuse Large B-Cell Lymphoma (Dlbcl): The Dlcl10 Multicenter Phase 2 Trial by Fondazione Italiana Linfomi (Fil)

Hematological Oncology

English

Baseline Total Metabolic Tumour Volume Is Highly Prognostic for Refractoriness to Immunochemotherapy in Dlbcl: An Analysis of the Phase 3 Goya Trial

Hematological Oncology

English

Pod24 and Cr30 Are Promising Surrogate Endpoints for Assessing the Outcome of Patients With Advanced Stage Follicular Lymphoma Enrolled in the Foll05 Trial by Fil.

Hematological Oncology

English

Improved Survival Outcomes for Patients With Extra-Nodal Nk/T Lymphoma: Data From 140 Patients Prospectively Registered in the International T-Cell Project

Hematological Oncology

English

Phase Ib Study of Cc-122 in Combination With Obinutuzumab (Ga101): Relapsed or Refractory (R/R) Patients With B-Cell Non-Hodgkin Lymphomas (Nhl)

Hematological Oncology

English

Clinical Characteristics of Patients With Negative Interim-Pet and Positive Final Pet: Data From the Prospective Pet-Oriented Hd0801 Study by Fondazione Italiana Linfomi (Fil)

Hematological Oncology

English

Novel Molecular Markers for Minimal Residual Disease (Mrd) Monitoring in Mantle Cell and Follicular Lymphoma: The Targeted Locus Amplification (Tla) NGS Strategy

Hematological Oncology

English

First Salvage Treatment With Bendamustine and Brentuximab Vedotin in Hodgkin Lymphoma: A Phase 2 Study of Fil Onlus

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by U. Vitolo

Integrating Tumor- And Microenvironment-Reflecting Genes in a Unique and Routine-Applicable Assay for Accurate Risk Prediction in DLBCL

Cell of Origin Combined With CNS International Prognostic Index Improves Identification of DLBCL Patients With High CNS Relapse Risk After Initial Immunochemotherapy

Pet-Driven Radiotherapy in Patients With Low Risk Diffuse Large B-Cell Lymphoma (Dlbcl): The Dlcl10 Multicenter Phase 2 Trial by Fondazione Italiana Linfomi (Fil)

Baseline Total Metabolic Tumour Volume Is Highly Prognostic for Refractoriness to Immunochemotherapy in Dlbcl: An Analysis of the Phase 3 Goya Trial

Pod24 and Cr30 Are Promising Surrogate Endpoints for Assessing the Outcome of Patients With Advanced Stage Follicular Lymphoma Enrolled in the Foll05 Trial by Fil.

Improved Survival Outcomes for Patients With Extra-Nodal Nk/T Lymphoma: Data From 140 Patients Prospectively Registered in the International T-Cell Project

Phase Ib Study of Cc-122 in Combination With Obinutuzumab (Ga101): Relapsed or Refractory (R/R) Patients With B-Cell Non-Hodgkin Lymphomas (Nhl)

Clinical Characteristics of Patients With Negative Interim-Pet and Positive Final Pet: Data From the Prospective Pet-Oriented Hd0801 Study by Fondazione Italiana Linfomi (Fil)

Novel Molecular Markers for Minimal Residual Disease (Mrd) Monitoring in Mantle Cell and Follicular Lymphoma: The Targeted Locus Amplification (Tla) NGS Strategy

First Salvage Treatment With Bendamustine and Brentuximab Vedotin in Hodgkin Lymphoma: A Phase 2 Study of Fil Onlus